RELOCATIONS; USE OF NAME Sample Clauses

RELOCATIONS; USE OF NAME. Relocate its executive offices, open new places of business or relocate existing places of business; maintain any Collateral or records with respect to Collateral at any other locations than those locations presently kept or maintained, as set forth on SCHEDULE 3.2 hereto; or use any corporate name (other than its own) or any fictitious name, in each case, except upon thirty (30) days prior written notice to the Agent and after the delivery to the Agent of financing statements, if required by the Agent, in form satisfactory to the Agent.
RELOCATIONS; USE OF NAME. Relocate its executive offices, open new places of business, relocate existing places of business, or use any corporate name (other than its own) or any fictitious name, in each case, except upon thirty (30) days prior written notice to the Lenders and after the delivery to the Lenders of financing statements, if required by the Lenders, in form satisfactory to the Lenders.
RELOCATIONS; USE OF NAME. Except as disclosed on Schedule 5.2 attached hereto, relocate its executive offices, open new places of business or relocate existing places of business, maintain any Collateral or records with respect to Collateral at any other locations than those locations presently kept or maintained, as set forth on Schedule 5.2 attached hereto, or use any corporate name (other than its own) or any fictitious name, except upon thirty (30) days prior written notice to the Agent and the Lenders and after the delivery to the Agent of financing statements, if required by the Agent, in form satisfactory to the Agent.
RELOCATIONS; USE OF NAME. Relocate its executive offices, open new places of business or relocate existing places of business; change its state of incorporation, maintain any Collateral or records with respect to Collateral at any other locations than those locations presently kept or maintained, as set forth on SCHEDULE 4.15 hereto; or use any corporate name (other than its own) or any fictitious name, in each case, except upon thirty (30) days prior written notice to the Lender and after the delivery to the Lender of financing statements, if required by the Lender, in form satisfactory to the Lender.
RELOCATIONS; USE OF NAME. Except as disclosed on Schedule 5.2 ------------ hereof, neither the Obligors nor any of their Subsidiaries shall (a) relocate its executive offices; (b) with the exception of new offices which have or generate less than $500,000 in assets, open new places of business or relocate existing places of business; (c) maintain any Collateral or records with respect to Collateral at any other locations than those locations presently kept or maintained, as set forth on Schedule 5.2 hereto; or (d) use any corporate name ------------ (other than its own) or any fictitious name, except upon thirty (30) days prior written notice to the Agent and after the delivery to the Agent of financing statements, if required by the Agent, in form satisfactory to the Agent.
RELOCATIONS; USE OF NAME. The Obligors shall not, and shall not permit any of their respective Subsidiaries to, relocate its executive office; open new places of business or relocate existing places of business, unless the Obligors notify the Agent in writing at least thirty (30) days prior to such opening or such relocation and promptly executes, or causes the applicable Subsidiary to execute, such UCC-1 financing statements and amendments to UCC-1 financing statements as the Agent may reasonably request; maintain any Collateral or any collateral under any Loan Document, at any locations and other than those locations set forth on SCHEDULE 6.15 hereto or those locations with respect to which the Agent has filed or caused to be filed such UCC financing statements as are required by Applicable Law to perfect the Agent's security interest in Collateral or collateral located at such location; or use any corporate name (other than its own) or any fictitious name; in each case except upon at least thirty (30) days prior written notice to the Agent and after the delivery to the Agent of financing statements, if required by the Agent, in form satisfactory to the Agent.
RELOCATIONS; USE OF NAME. Relocate its executive offices, open new places of business or relocate existing places of business; maintain any Collateral or records with respect to Collateral at any other locations than those locations presently kept or maintained, as set forth on SCHEDULE 3.2 hereto; or use any corporate name (other than its own) or any fictitious name, in each case, except upon thirty (30) days written notice to Alexander Enterprise and after the delivery to Alexander Enterprise of financing statements, if required by Alexander Enterprise, in form satisfactory to Alexander Enterprise.
RELOCATIONS; USE OF NAME. The Borrower shall not, and shall not permit any of its Subsidiaries to, relocate its executive offices, open new places of business or relocate existing places of business; maintain any Collateral or records with respect to Collateral at any other locations than those locations presently kept or maintained, as set forth on Schedule 5.15 hereto; or use any corporate name (other than its own) or any fictitious name, in each case, except upon thirty (30) days prior written notice to the Collateral Agent and after the delivery to the Collateral Agent of financing statements, if required by the Collateral Agent, in form satisfactory to the Collateral Agent.
RELOCATIONS; USE OF NAME. Relocate its executive office; maintain any Collateral at any location other than the Mortgaged Property or maintain records with respect to Collateral at any locations other than the Mortgaged Property or at the location of its chief executive office set forth in Section 5.2 hereto; or use any corporate name (other than its own) or any fictitious name except upon thirty (30) days prior written notice to Agent and after the delivery to Agent of financing statements, if required by Agent, in form satisfactory to Agent.

Related to RELOCATIONS; USE OF NAME

  • NON-USE OF NAMES Neither Party shall use the name of the other Party, nor any adaptation thereof, in any advertising, promotional or sales literature without prior written consent obtained from such other Party in each case (which consent shall not be unreasonably withheld or delayed).

  • Publicity; Use of Names Neither Party shall use the name, trademark, trade name or logo of the other Party, its Affiliates or their respective employee(s) in any publicity, promotion, news release or disclosure relating to this Agreement or its subject matter, without the prior express written permission of the other Party, except for those disclosures expressly authorized under this Article 4. Following execution of this Agreement, either Party may issue a press release announcing the existence of this Agreement in form and substance agreed to in writing by both Parties, such agreement to not be unreasonably withheld or delayed. Each Party agrees not to issue any other press release or other public statement disclosing other information relating to this Agreement or the transactions contemplated hereby without the prior written consent of the other Party, which consent shall not be unreasonably withheld or delayed; provided that Arvinas agrees that it shall be deemed reasonable for Pfizer to withhold its consent for the disclosure of any information related to a Target or a specific Compound or the amount of any payment made or to be made under this Agreement; and provided further that any disclosure which is required by Law or the rules of a securities exchange, as reasonably advised by the disclosing Party’s counsel, may be made subject to the following. Each Party agrees to provide to the other Party a copy of any public announcement regarding this Agreement or the subject matter thereof as soon as reasonably practicable under the circumstances prior to its scheduled release. Except under extraordinary circumstances or to the extent any such advance notice or notice period is not consistent with applicable Law, each Party shall provide the other with an advance copy of any such announcement at least [**] prior to its scheduled release. Each Party shall have the right to expeditiously review and recommend changes to any such announcement and, except as otherwise required by Law, the Party whose announcement has been reviewed shall remove any information the reviewing Party reasonably deems to be inappropriate for disclosure. The contents of any announcement or similar publicity which has been reviewed and approved by the reviewing Party can be re-released by either Party without a requirement for re-approval. In addition, except to the extent required by Laws in connection with patent enforcement activities conducted in accordance with Article 7, Pfizer shall not use the name “Yale” or “Yale University,” nor any variation or adaptation thereof, nor any trademark, trade name or other designation owned by Yale University, nor the names of any of its trustees, officers, faculty, students, employees or agents, for any purpose without the prior written consent of Yale University in each instance, such consent to be granted or withheld by Yale University in its sole discretion, except that Pfizer may state that it has sublicensed from Yale University one or more of the patents or applications comprising the Yale Licensed Patents.

  • SERVICES NOT EXCLUSIVE/USE OF NAME Your (and a sub-adviser’s) services to the Fund(s) pursuant to this Agreement are not to be deemed to be exclusive, and it is understood that you (or a sub-adviser) may render investment advice, management and other services to others, including other registered investment companies, provided, however, that such other services and activities do not, during the term of this Agreement, interfere in a material manner, with your ability to meet all of your obligations with respect to rendering services to the Funds. The Trust and you acknowledge that all rights to the name “LoCorr” or any variation thereof belong to you, and that the Trust is being granted a limited license to use such words in any Fund name or in any class name. In the event you cease to be the adviser to a Fund, the Trust’s right to the use of the name “LoCorr” with respective to such Fund shall automatically cease on the 90th day following the termination of this Agreement. The right to the name may also be withdrawn by you during the term of this Agreement upon ninety (90) days’ written notice by you to the Trust. Nothing contained herein shall impair or diminish in any respect, your right to use the name “LoCorr” in the name of or in connection with any other business enterprises with which you are or may become associated. There is no charge to the Trust for the right to use this name.

  • Use of Name (a) The Sub-Adviser hereby consents to the use of its name and the names of its affiliates in the Fund’s disclosure documents, shareholder communications, advertising, sales literature and similar communications. The Sub-Adviser shall not use the name or any tradename, trademark, trade device, service ▇▇▇▇, symbol or any abbreviation, contraction or simulation thereof of the Adviser, the Trust, the Fund or any of their affiliates in its marketing materials unless it first receives prior written approval of the Trust and the Adviser. (b) It is understood that the name of each party to this Agreement, and any derivatives thereof or logos associated with that name, is the valuable property of the party in question and its affiliates, and that each other party has the right to use such names pursuant to the relationship created by, and in accordance with the terms of, this Agreement only so long as this Agreement shall continue in effect. Upon termination of this Agreement, the parties shall forthwith cease to use the names of the other parties (or any derivative or logo) as appropriate and to the extent that continued use is not required by applicable laws, rules and regulations.

  • No Use of Name Supplier shall not use, or permit the use of, the name, trade name, service marks, trademarks, or logo of EY or of any EY Network Member in any form of publicity, press release, advertisement, or otherwise without EY’s prior written consent.